Detalhe da pesquisa
1.
Abelacimab for Prevention of Venous Thromboembolism.
N Engl J Med
; 385(7): 609-617, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297496
2.
Milvexian for the Prevention of Venous Thromboembolism.
N Engl J Med
; 385(23): 2161-2172, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780683
3.
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
N Engl J Med
; 378(7): 615-624, 2018 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29231094
4.
Clinical implications of incidental venous thromboembolism in cancer patients.
Eur Respir J
; 55(2)2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727694
5.
Factor XI antisense oligonucleotide for prevention of venous thrombosis.
N Engl J Med
; 372(3): 232-40, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25482425
6.
Edoxaban for Cancer-Associated Venous Thromboembolism.
N Engl J Med
; 379(1): 95-96, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29972743
7.
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
N Engl J Med
; 369(15): 1406-15, 2013 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23991658
8.
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
N Engl J Med
; 366(14): 1287-97, 2012 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22449293
9.
Oral rivaroxaban for symptomatic venous thromboembolism.
N Engl J Med
; 363(26): 2499-510, 2010 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21128814
10.
Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study.
J Thromb Haemost
; 21(10): 2929-2940, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178771
11.
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
J Thromb Haemost
; 19(12): 3008-3017, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34455706
12.
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
Blood
; 112(6): 2242-7, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18621928
13.
Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH.
J Thromb Haemost
; 18(6): 1495-1500, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32496023
14.
Development of a standardized definition of pulmonary embolism-related death: A cross-sectional survey of international thrombosis experts.
J Thromb Haemost
; 18(6): 1415-1420, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073218
15.
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
J Thromb Haemost
; 17(11): 1866-1874, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31271705
16.
Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
J Thromb Haemost
; 17(12): 2081-2088, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31529590
17.
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent.
TH Open
; 2(1): e1-e7, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31249922
18.
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.
Thromb Res
; 162: 7-14, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248859
19.
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
Thromb Haemost
; 118(8): 1439-1449, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30060256
20.
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
Thromb Haemost
; 117(12): 2406-2414, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212128